Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sutro Biopharma (STRO) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Pembrolizumab, Stro-006Colorectal Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Breast Cancer, Gastric Cancer, Esophageal Cancer, Urothelial Carcinoma (Uc), Head & Neck Squamous Cell CarcinomaPhase IRecruitingPhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticAug 31, 2026―
Pembrolizumab, Stro-004Colorectal Cancer, Endometrial Cancer, Cervical Cancer, Gastric Cancer, Urothelial Cancer, Esophageal Cancer, Non-Small Cell Lung Cancer Nsclc, Pancreatic Ductal Adenocarcinoma (Pdac), Head And Neck Squamous Cell Carcinoma HnsccPhase IRecruitingA Study of STRO-004 in Adults With Refractory/Recurrent Metastatic CancerNov 07, 2025
Luveltamab TazevibulinAcute Myeloid Leukemia (Aml)phase1AndPhase2TerminatedLuveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLNov 02, 2024―
Luveltamab TazevibulinLung Cancer, Lung Cancer, Non-Small Cell, Lung Cancer Metastatic, Lung Cancer, Nonsmall Cell, Lung Cancer Non-Small Cell Stage Iiib, Lung Cancer Non-Small Cell Stage IvPhase IIWithdrawnStudy to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung CancerAug 12, 2024―
Gemcitabine, Paclitaxel, Topotecan, Pegylated Liposomal Doxorubicin, Luveltamab Tazevibulin, PegfilgrastimEpithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Platinum-Resistant Ovarian Cancer, Primary Peritoneal Cancerphase2AndPhase3TerminatedREFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1May 12, 2023―
Bevacizumab, Stro-002Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Ovary CancerPhase ITerminatedA Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian CancerDec 19, 2021―
Stro-002Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Endometrioid AdenocarcinomaPhase ICompletedStudy of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial CancersNov 13, 2018―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sutro Biopharma (STRO) have in its pipeline
Sutro Biopharma STRO is currently developing the following drugs: Pembrolizumab, Stro-006, Pembrolizumab, Stro-004, Luveltamab Tazevibulin, Gemcitabine, Paclitaxel, Topotecan, Pegylated Liposomal Doxorubicin, Luveltamab Tazevibulin, Pegfilgrastim, Bevacizumab, Stro-002, Stro-002. These drug candidates are in various stages of clinical development as the company works toward FDA approval.